Nicolas Magné
Researcher Next ID · RN-022165
Researcher · Medicine
Centre National de la Recherche Scientifique
Paris, Colombia
- Works count
- 463
- Citation count
- 10,350
- H-index
- 54
- i10-index
- 184
Research interests
Publications
Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial
The Lancet. Gastroenterology & hepatology · 2023 · 10.1016/s2468-1253(22)00392-2
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)00367-1
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
The Lancet Oncology · 2020 · 10.1016/s1470-2045(20)30454-x
Radiation-induced bystander and abscopal effects: important lessons from preclinical models
British Journal of Cancer · 2020 · 10.1038/s41416-020-0942-3
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study
The Lancet Oncology · 2020 · 10.1016/s1470-2045(20)30327-2
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
The Lancet Oncology · 2019 · 10.1016/s1470-2045(19)30486-3
Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies
Critical Reviews in Oncology/Hematology · 2018 · 10.1016/j.critrevonc.2018.09.004
Nanoparticles in radiation oncology: From bench-side to bedside
Cancer Letters · 2016 · 10.1016/j.canlet.2016.03.011
Can immunostimulatory agents enhance the abscopal effect of radiotherapy?
European Journal of Cancer · 2016 · 10.1016/j.ejca.2016.03.067
Radiation-enhanced cell migration/invasion process: A review
Critical Reviews in Oncology/Hematology · 2014 · 10.1016/j.critrevonc.2014.05.006
Targeting Head and Neck Cancer Stem Cells to Overcome Resistance to Photon and Carbon Ion Radiation
Stem Cell Reviews and Reports · 2013 · 10.1007/s12015-013-9467-y
Targeting a cornerstone of radiation resistance: Cancer stem cell
Cancer Letters · 2012 · 10.1016/j.canlet.2012.03.024
Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients
Critical Reviews in Oncology/Hematology · 2010 · 10.1016/j.critrevonc.2010.08.004
Physics Contributions and Clinical Outcome With 3D-MRI–Based Pulsed-Dose-Rate Intracavitary Brachytherapy in Cervical Cancer Patients
International Journal of Radiation Oncology*Biology*Physics · 2008 · 10.1016/j.ijrobp.2008.06.1912
Phyllodes Tumor of the Breast
International Journal of Radiation Oncology*Biology*Physics · 2007 · 10.1016/j.ijrobp.2007.06.059
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy
Annals of Oncology · 2007 · 10.1093/annonc/mdm548
Outcome and prognostic factors in breast sarcoma: A multicenter study from the rare cancer network
Radiotherapy and Oncology · 2007 · 10.1016/j.radonc.2007.10.015
Radiation recall: A well recognized but neglected phenomenon
Cancer Treatment Reviews · 2005 · 10.1016/j.ctrv.2005.07.008
Pharmacological background of EGFR targeting
Annals of Oncology · 2004 · 10.1093/annonc/mdh257
Prognostic Value of Tumoral Thymidylate Synthase and p53 in Metastatic Colorectal Cancer Patients Receiving Fluorouracil-Based Chemotherapy: Phenotypic and Genotypic Analyses
Journal of Clinical Oncology · 2002 · https://doi.org/10.1200/jco.2002.09.091
Sequence-dependent effects of ZD1839 (‘Iressa’) in combination with cytotoxic treatment in human head and neck cancer
British Journal of Cancer · 2002 · 10.1038/sj.bjc.6600103
Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’)
British Journal of Cancer · 2002 · 10.1038/sj.bjc.6600299
Percutaneous cementoplasty for pelvic bone metastasis
Supportive Care in Cancer · 2000 · 10.1007/s005200000138
Current projects
No projects listed.